Table 5 Score allocations of the identified modifiers for the prevention of therapeutic duplication or drug interaction
Variables | Scoring system I | Scoring system II |
|---|---|---|
Sex (Female) | 0.58 | 0.49 |
Types of drugs (≥ 6) | 0.16 | -0.05 |
Medical institutions used (≥ 2) | 0.08 | -0.07 |
Proton pump inhibitors | 0.08 | -0.17 |
Antibiotics | 0.01 | -0.03 |
Probiotics | 0.32 | 0.29 |
Traditional Japanese herbal medicines | 0.37 | 0.45 |